Up 10% in October: an AI-picked stock defied Asia’s $2 trillion chip rout
In October, an AI-powered stock selection defied Asia's $2 trillion chip sector rout. The Nikkei and Kospi saw declines of 2% and 1.6% respectively, driven by profit-taking in SK Hynix and Samsung, and concerns that AI spending outpaced actual revenue. However, defensive and cash-generative healthcare stocks emerged as strong performers.
The Healthcare Heroes strategy, which screens the S&P 500 health-care sector monthly, saw a 22.10% gain since its August 15, 2025 launch, outperforming the sector benchmark by 7.3 percentage points. AbbVie topped the list with a 10.5% gain this month, trading at $285.42, just 2.1% below its 52-week high. The strategy's other holdings also gained, with an equal-weighted average increase of over 6%.
Other Strategies, Small-Cap Sprinters and Dominate the Dow, also rode the rotation, with the former up 29.68% and the latter 18.29% since the start of 2026. This stands in stark contrast to the chip sector, where companies like Intel, Applied Materials, Lam Research, and Onto Innovation suffered double-digit declines. The AI-powered system evaluates thousands of equities each month, using over 15 years of financial data and 150 quantitative models to identify high-conviction stocks with medium-term upside potential.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
